Shimadzu Corporation Stock price

Equities

7701

JP3357200009

Office Equipment

Market Closed - Japan Exchange 02:00:00 2024-03-29 am EDT 5-day change 1st Jan Change
4,230 JPY +0.64% Intraday chart for Shimadzu Corporation -4.64% +7.31%
Sales 2024 * 511B 3.38B Sales 2025 * 529B 3.5B Capitalization 1,239B 8.19B
Net income 2024 * 55.17B 365M Net income 2025 * 57.19B 378M EV / Sales 2024 * 2.05 x
Net cash position 2024 * 192B 1.27B Net cash position 2025 * 224B 1.48B EV / Sales 2025 * 1.92 x
P/E ratio 2024 *
22.5 x
P/E ratio 2025 *
21.7 x
Employees 13,898
Yield 2024 *
1.37%
Yield 2025 *
1.42%
Free-Float 97.53%
More Fundamentals * Assessed data
Dynamic Chart
Shimadzu Corporation acquired Gas chromatograph (GC) catalytic microreactor Business from Activated Research Company, LLC. CI
Certain Common Stock of AR advanced technology, Inc. are subject to a Lock-Up Agreement Ending on 19-DEC-2023. CI
MiCAN Technologies Inc. announced that it has received ¥200 million in funding from RealTechJapan LLC., Fujimori Kogyo Co., Ltd., Shimadzu Corporation CI
IMMUNOSENS Co. Ltd. announced that it has received funding from Global Brain Co., Ltd., Shimadzu Corporation CI
AR advanced technology, Inc. has completed an IPO in the amount of ¥924.21 million. CI
Shyld AI and Shimadzu Corporation Team Up with the Goal of Revolutionizing Healthcare with Groundbreaking AI-Powered UV-C Disinfection Technology CI
Jefferies Adjusts Shimadzu's Price Target to 5,500 Yen From 5,000 Yen, Keeps at Buy MT
Shimadzu Corporation acquired Biomaneo. CI
AR advanced technology, Inc. has filed an IPO. CI
Shimadzu Corporation Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Jefferies Adjusts Shimadzu's Price Target to 5,000 Yen From 5,500 Yen, Keeps at Buy MT
New entries in the Asia Investor Portfolio Our Logo
Shimadzu Corp. Shares Rise on Higher First-Half Profit DJ
Shimadzu Corporation completed the acquisition of 34.7% stake in Nissui Pharmaceutical Co., Ltd. for ¥13.3 billion. CI
Shimadzu Corporation made an offer to acquire a 45.9% stake in Nissui Pharmaceutical Co., Ltd. for ¥17.6 billion. CI
More news
1 day+0.64%
1 week-4.64%
Current month+3.60%
1 month+3.60%
3 months+7.31%
6 months+6.50%
Current year+7.31%
More quotes
1 week
4 175.00
Extreme 4175
4 436.00
1 month
4 051.00
Extreme 4051
4 496.00
Current year
3 745.00
Extreme 3745
4 496.00
1 year
3 493.00
Extreme 3493
4 637.00
3 years
3 493.00
Extreme 3493
5 550.00
5 years
2 148.00
Extreme 2148
5 550.00
10 years
801.00
Extreme 801
5 550.00
More quotes
Managers TitleAgeSince
Director of Finance/CFO - -
President 65 83-03-31
Chairman 66 82-03-31
Members of the board TitleAgeSince
Director/Board Member 70 20-05-31
Comptroller/Controller/Auditor 69 81-03-31
Director/Board Member 69 21-05-31
More insiders
Date Price Change Volume
24-03-29 4,230 +0.64% 721 900
24-03-28 4,203 -3.58% 1,151,000
24-03-27 4,359 -0.30% 1,011,500
24-03-26 4,372 +0.83% 639,700
24-03-25 4,336 -2.25% 689,800

Delayed Quote Japan Exchange, March 29, 2024 at 02:00 am EDT

More quotes
Shimadzu Corp is a Japan-based company mainly engaged in the research, development, manufacture, sale and maintenance of scientific and precision equipment. The Company has four segments. Testing and Measuring Instruments segment is engaged in the provision of chromatographic analysis systems, mass spectrometry systems, light analysis systems, thermal analysis systems, bio-related analysis systems, water quality measurement systems and others. Medical Equipment segment is engaged in the provision of X-ray television (TV) systems, angiography systems, X-ray imaging systems and others. Aircraft Equipment segment is engaged in the provision of flight control systems, air management systems, cockpit display systems and others. Industrial Equipment segment is engaged in the provision of turbomolecular pumps and others. The Company is also engaged in the leasing and management of real estate business.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
4,203 JPY
Average target price
5,176 JPY
Spread / Average Target
+23.15%
Consensus
  1. Stock
  2. Equities
  3. Stock Shimadzu Corporation - Japan Exchange